Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(59 sites)

United States

Clinical Site, Dothan, Alabama

Clinical Site, Little Rock, Arkansas

Clinical Site, Anaheim, California

Clinical Site, Redlands, California

Clinical Site, Sacramento, California